Clinical Trial Update: Effects of Salmeterol on Autonomic Nervous System [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effects of salmeterol on the autonomic nervous system in chronic obstructive pulmonary disease; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Serevent (salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2014-02-04